MARGARITA TABUDLONG: Open Payments
NPI 1326808148 · CROFTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$948 in 45 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $948 · 2025 $948
Food & beverage: $948
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $183 |
| Lilly USA, LLC | 7 | $138 |
| Amphastar Pharmaceuticals, Inc. | 5 | $95 |
| Xeris Pharmaceuticals, Inc. | 4 | $72 |
| Tandem Diabetes Care, Inc. | 2 | $61 |
| Amneal Pharmaceuticals LLC | 2 | $46 |
| Amgen Inc. | 2 | $37 |
| Insulet Corporation | 1 | $35 |
| ABBVIE INC. | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: Ozempic, GVOKE HYPOPEN, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, UNITHROID, EVENITY, Omnipod.
Industry payments across MD — which companies pay providers there.
